BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2981593)

  • 1. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.
    Aiuti F; Rossi P; Sirianni MC; Carbonari M; Popovic M; Sarngadharan MG; Contu L; Moroni M; Romagnani S; Gallo RC
    Br Med J (Clin Res Ed); 1985 Jul; 291(6489):165-6. PubMed ID: 2990634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG antibodies to HTLV-III associated antigens in patients with AIDS and at risk for AIDS in The Netherlands.
    Goudsmit J; Tersmette T; Kabel P; Miedema F; Melief C
    AIDS Res; 1983-1984; 1(4):231-6. PubMed ID: 6100824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men.
    Goedert JJ; Sarngadharan MG; Biggar RJ; Weiss SH; Winn DM; Grossman RJ; Greene MH; Bodner AJ; Mann DL; Strong DM
    Lancet; 1984 Sep; 2(8405):711-6. PubMed ID: 6148471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of HTLV-III seropositivity and lymphadenopathy.
    Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR
    Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
    Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC
    Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Lancet; 1984 Nov; 2(8411):1094. PubMed ID: 6150160
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.
    Sarngadharan MG; Popovic M; Bruch L; Schüpbach J; Gallo RC
    Science; 1984 May; 224(4648):506-8. PubMed ID: 6324345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vancouver Lymphadenopathy-AIDS Study: 3. Relation of HTLV-III seropositivity, immune status and lymphadenopathy.
    Boyko WJ; Schechter MT; Jeffries E; Douglas B; Maynard M; O'Shaughnessy M
    Can Med Assoc J; 1985 Jul; 133(1):28-32. PubMed ID: 2988730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
    Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
    Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-I-specific antibody in AIDS patients and others at risk.
    Robert-Guroff M; Blayney DW; Safai B; Lange M; Gelmann EP; Gutterman JW; Mansell PW; Goedert JL; Groopman JE; Steigbigel NH
    Lancet; 1984 Jul; 2(8395):128-31. PubMed ID: 6146035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.
    Abb J
    Med Microbiol Immunol; 1985; 174(4):205-10. PubMed ID: 2999573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals.
    Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Chieco-Bianchi L
    Tumori; 1986 Jun; 72(3):219-24. PubMed ID: 3016957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D; Dewhurst S; Sonnabend J; Sinangil F; Purtilo DT; Volsky DJ
    AIDS Res; 1984-1985; 1(6):407-21. PubMed ID: 6085926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
    Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
    J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men.
    Dobozin BS; Judson FN; Cohn DL; Penley KA; Rickmann PE; Blaser MJ; Sarin PS; Weiss SH; Kirkpatrick CH
    Cell Immunol; 1986 Mar; 98(1):156-71. PubMed ID: 3017581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.
    Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R
    Blood; 1985 Sep; 66(3):742-4. PubMed ID: 2992644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.